Knopman DS - Search Results

1

A phase 3 trial of IV immunoglobulin for Alzheimer disease.

Relkin NR, Thomas RG, Rissman RA, Brewer JB, Rafii MS, van Dyck CH, Jack CR, Sano M, Knopman DS, Raman R, Szabo P, Gelmont DM, Fritsch S, Aisen PS; Alzheimer's Disease Cooperative Study. Relkin NR, et al. Among authors: knopman ds. Neurology. 2017 May 2;88(18):1768-1775. doi: 10.1212/WNL.0000000000003904. Epub 2017 Apr 5. Neurology. 2017. PMID: 28381506 Free PMC article. Clinical Trial.

2

The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.

Knopman DS, Knapp MJ, Gracon SI, Davis CS. Knopman DS, et al. Neurology. 1994 Dec;44(12):2315-21. doi: 10.1212/wnl.44.12.2315. Neurology. 1994. PMID: 7991118 Clinical Trial.

3

Observations on the short-term 'natural history' of probable Alzheimer's disease in a controlled clinical trial.

Knopman D, Gracon S. Knopman D, et al. Neurology. 1994 Feb;44(2):260-5. doi: 10.1212/wnl.44.2.260. Neurology. 1994. PMID: 8309570 Clinical Trial.

4

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group.

Knopman D, Schneider L, Davis K, Talwalker S, Smith F, Hoover T, Gracon S. Knopman D, et al. Neurology. 1996 Jul;47(1):166-77. doi: 10.1212/wnl.47.1.166. Neurology. 1996. PMID: 8710072 Clinical Trial.

5

A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group.

Thal LJ, Schwartz G, Sano M, Weiner M, Knopman D, Harrell L, Bodenheimer S, Rossor M, Philpot M, Schor J, Goldberg A. Thal LJ, et al. Neurology. 1996 Dec;47(6):1389-95. doi: 10.1212/wnl.47.6.1389. Neurology. 1996. PMID: 8960716 Clinical Trial.

6

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, Sano M, Bieliauskas L, Geldmacher D, Clark C, Thal LJ. Mohs RC, et al. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S13-21. Alzheimer Dis Assoc Disord. 1997. PMID: 9236948

7

Long-term tacrine treatment effects.

Knopman D, Schneider L, Davis K, Gracon S, Smith F. Knopman D, et al. Neurology. 1998 Feb;50(2):567-8. doi: 10.1212/wnl.50.2.567. Neurology. 1998. PMID: 9484404 Clinical Trial. No abstract available.

8

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P. Galasko D, et al. Arch Neurol. 1998 Jul;55(7):937-45. doi: 10.1001/archneur.55.7.937. Arch Neurol. 1998. PMID: 9678311 Clinical Trial.

9

Nursing home placement is related to dementia progression: experience from a clinical trial. Alzheimer's Disease Cooperative Study.

Knopman DS, Berg JD, Thomas R, Grundman M, Thal LJ, Sano M. Knopman DS, et al. Neurology. 1999 Mar 10;52(4):714-8. doi: 10.1212/wnl.52.4.714. Neurology. 1999. PMID: 10078715 Clinical Trial.

10

Cardiovascular risk factors and cognitive decline in middle-aged adults.

Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern P, Folsom AR; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Knopman D, et al. Neurology. 2001 Jan 9;56(1):42-8. doi: 10.1212/wnl.56.1.42. Neurology. 2001. PMID: 11148234

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,047 results

Search Page